Last reviewed · How we verify
NCT05406895
Use of CBCT to Improve Inferior Alveolar Nerve Block Success
NA trial testing 2% Lidocaine with 1:100,000 epinephrine in Inferior Alveolar Nerve in 2 participants. Completed in 30 March 2024.
30 March 2024
Quick facts
| Lead sponsor | Louisiana State University Health Sciences Center in New Orleans |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 2 |
| Start date | 25 May 2022 |
| Primary completion | 30 March 2024 |
| Estimated completion | 30 March 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- 2% Lidocaine with 1:100,000 epinephrine — full drug profile →
Conditions studied
- Inferior Alveolar Nerve — all drugs for Inferior Alveolar Nerve →
- Mandibular Nerve Blocks — all drugs for Mandibular Nerve Blocks →
Sponsor
Louisiana State University Health Sciences Center in New Orleans
Who can join
Adults 18 to 70, any sex, with Inferior Alveolar Nerve or Mandibular Nerve Blocks. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study looks to compare the success rate of lower jaw anesthesia injection (inferior alveolar nerve) that is guided by pre-treatment 3D dental scan (CBCT) versus standard injection technique.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05406895
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of 2% Lidocaine with 1:100,000 epinephrine
Trials testing the same drug.
- NCT03368391 — : Pulpal Blood Flow With the Use of Intra-nasal Anesthetic · Phase 4 · unknown
Other Louisiana State University Health Sciences Center in New Orleans trials
Trials by the same sponsor.
- NCT07462767 — Precision Microbiota Interventions for Senoreduction Trial · Phase 1, PHASE2 · not yet recruiting
- NCT07488156 — Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder · NA · not yet recruiting
- NCT07280260 — Clinical Performance of Nobel N1 System · Phase 4 · recruiting
- NCT06773715 — Virtual Reality As Adjunct Therapy for Vaso-Occlusive Pain · NA · recruiting
- NCT06874244 — Clinical Evaluation of no Needle Dental Anesthesia Compared to Syringe Anesthesia Delivery · EARLY_PHASE1 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05406895 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Louisiana State University Health Sciences Center in New Orleans
- Last refreshed: 3 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05406895.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing